Office for People With Developmental Disabilities

Print: Print this page

IBR Seminars—2008

07/19/12

January 10

Jeffrey Goodman, PhD, Center for Neural Recovery and Rehabilitation, Helen Hayes Hospital, West Havestraw, New York
Developmental Hypothyroid Induces a Cellular Malformation in the Corpus Callosum of the Rat

April 10

Khalid M. Khan, PhD, Department of Anatomy, Faculty of Medicine, Kuwait University, Safat, Kuwait
Olivochohlear Pathway: Characterization and Localization of Receptors in the Mammalian Cochlea

April 17‐18

2nd Annual Elizabeth A. Connelly Memorial Conference: Autism: Prenatal and Perinatal Factors, and Evidence‐Based Assessment and Intervention

May 12

Elizabeth Schonauer, BSc, and Melianie Duquette, HBSc, DNA Genetek, Inc.
High DNA and RNA Recovery from Saliva using Patented Technology

June 3rd

Paul C. Muzio, CUNY High Performance Computing Facility, CUNY – College of Staten Island
The Supercomputing Revolution: Software as DNA

June 11

Sandra Wilson, PhD, Department of Biological Sciences, Stanford University, CA
Primary Cilia Control on Brain Size Through the Regulation of GL13 Processing

June 12

XiaoChing Li, PhD, LSU Neuroscience Center of Excellence, New Orleans, LA
Genes, Neurons and Vocal Behavior in Songbirds and their Relevance to Autism

June 20

Evgeni G. Ponimaskin, PhD, Department of Neuro and Sensory Physiology & Center of Molecular Physiology of the Brain, Medical School University of Goettingen, Germany
New Serotonergic Pathways Regulating Neuronal Morphology and Synaptic Plasticity

July 22

Israel Abramov, PhD, Department of Psychology, Brooklyn College of CUNY, Biopsychology and Behavioral Neuroscience, Graduate Center of CUNY
Vision and the 23rd Chromosome

October 8

Symposium on Future Therapeutics of Alzheimer’s Disease and Related Neurodegenerative Disorders

Nikolaos Robakis, PhD, Mount Sinai School of Medicine, New York City
P13 Kinase Signal Transduction and Presenilin‐1

Emmanuel Planel, PhD, Columbia University, New York City
Impact of Anesthesia on Tau Pathology: From Mechanism to Treatment

David Vocadlo, PhD, Simon Fraser University, British Columbia, Canada
Inhibition of Neurofibrillary Degeneration by Increasing O‐GlcNAcylation of Tau

Illana Gozes, PhD, Tel Aviv University, Tel Aviv, Israel
Addressing Alzheimer’s Disease Microtubules: From NAP to AL‐108

Einar M. Sigurdsson, PhD, New York University Medical School, New York City
Immunotherapy Targeting Pathological Tau in Alzheimer’s Disease and Related Tauopathies

December 4

Dr. Nan_Shan Chang, The National Cheng Kung University Medical College, Tainan, Taiwan; The Medical University of South Carolina, SC; and the Upstate Medical University, NY
Role of Tumor Suppressor WWOX in Neurodevelopment and Neurodegeneration